BINOSTO(TM) - First and Only Buffered Effervescent Solution for the Treatment of Osteoporosis Launched in the USA / EffRx to Regain Rights Outside of North America
Freienbach, Switzerland (ots) - EffRx Pharmaceuticals SA is proud to announce that BINOSTO (TM) (alendronate sodium) Effervescent Tablet for buffered oral solution (70 mg) is now available by prescription in the United States. The U.S. Food and Drug Administration earlier this year approved BINOSTO to treat ...
mehr